Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Apotex has received support from two pharmaceutical companies to manufacture generic fixed-dose combination antiretroviral medicines in Canada,

    This is a preview of subscription content, log in to check access.

    REFERENCE

    1. 1.

      GlaxoSmithKline.GSK gives consent under Canada's Access to Medicines Regime for generic version of HIV/AIDS medicine for use in Rwanda. Media Release: 8 Aug 2007. Available from: URL: http://www.gsk.com

    2. 2.

      Shire plc.Shire supports Canada's Access to Medicines Regime. Media Release: 15 Aug 2007. Available from: URL: http://www.shire.com

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Apotex has received support from two pharmaceutical companies to manufacture generic fixed-dose combination antiretroviral medicines in Canada,. Pharmacoecon. Outcomes News 535, 14 (2007). https://doi.org/10.2165/00151234-200705350-00036

    Download citation

    Keywords

    • Public Health
    • Health Outcome
    • Health Economic
    • Pharmaceutical Company
    • Lamivudine